Latest Breaking News On - Controversy around falsified alzheimer research - Page 1 : comparemela.com

DGAP-News: NervGen Pharma Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure? 08.09.2022 / 22:47 CET/CEST The issuer is solely responsible

United statesMatthew schraggNervgen pharmaPaul brennanNancy thompsonSylvain lesnNational institute of healthEisai coBiogen incNervgen pharma corpDistribution servicesControversy around falsified alzheimer researchPfizer incAlzheimer research go fromNews serviceNational institute